gliclazide has been researched along with D-fructopyranose in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Crimi, S; Di Mauro, M; Lunetta, M; Mughini, L | 1 |
Maciążek-Jurczyk, M; Pożycka, J; Szkudlarek, A | 1 |
Cheng, X; Qiu, L; Wang, F | 1 |
1 trial(s) available for gliclazide and D-fructopyranose
Article | Year |
---|---|
No important differences in glycaemic responses to common fruits in type 2 diabetic patients.
Topics: Analysis of Variance; Bread; Citrus; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Dietary Fiber; Female; Fructose; Fruit; Gliclazide; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Sucrose; Time Factors | 1995 |
2 other study(ies) available for gliclazide and D-fructopyranose
Article | Year |
---|---|
Influence of Piracetam on Gliclazide-Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study.
Topics: Fructose; Gliclazide; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Kinetics; Models, Molecular; Molecular Conformation; Molecular Structure; Piracetam; Protein Binding; Serum Albumin; Serum Albumin, Human; Spectrometry, Fluorescence | 2018 |
18α-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cell Survival; Cytokines; Dyslipidemias; Fatty Acids; Fructose; Glycyrrhetinic Acid; Glycyrrhiza; Humans; Inflammation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitochondria; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress | 2020 |